Norinchukin Bank, The Pfizer Inc Transaction History

Norinchukin Bank, The

$3.46 Billion
Q2 2024

A detailed history of Norinchukin Bank, The transactions in Pfizer Inc stock. As of the latest transaction made, Norinchukin Bank, The holds 200,462 shares of PFE stock, worth $5.96 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

200,462

Previous 196,618 1.96%

Holding current value

$5.96 Million

Previous $5.46 Million 2.79%

% of portfolio

0.16%

Previous 0.16%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $97,099 - $113,782	3,844 Added 1.96%	200,462 $5.61 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $70,317 - $80,746	-2,716 Reduced 1.36%	196,618 $5.46 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $548,285 - $712,163	-20,983 Reduced 9.52%	199,334 $5.74 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $7.07 Million - $8.26 Million	220,317 New	220,317 $7.31 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $5.39 Million - $6.23 Million	149,134 Added 44.87%	481,500 $17.7 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $430,887 - $560,951	10,939 Added 3.4%	332,366 $13.6 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $2.45 Million - $3.19 Million	-58,607 Reduced 15.42%	321,427 $16.5 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1.47 Million - $1.79 Million	33,540 Added 9.68%	380,034 $16.6 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $7.79 Million - $9.24 Million	-167,428 Reduced 32.58%	346,494 $18.2 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $1.53 Million - $1.9 Million	33,435 Added 6.96%	513,922 $26.6 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $104,539 - $154,962	-2,530 Reduced 0.52%	480,487 $28.4 Million
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $778,837 - $1 Million	19,843 Added 4.28%	483,017 $20.8 Million
Q2 2021 Aug 11, 2021	SELL	$35.91 - $40.68 $27,291 - $30,916	-760 Reduced 0.16%	463,174 $18.1 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $302,079 - $340,685	9,020 Added 1.98%	463,934 $16.8 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $457,200 - $581,369	-13,660 Reduced 2.92%	454,914 $16.7 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $601,630 - $705,850	-18,949 Reduced 3.89%	468,574 $17.2 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $601,586 - $729,813	-19,973 Reduced 3.94%	487,523 $15.9 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $11.9 Million - $17.1 Million	-441,893 Reduced 46.54%	507,496 $16.6 Million
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $1.96 Million - $2.22 Million	-59,530 Reduced 5.9%	949,389 $37.2 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $571,239 - $740,729	17,582 Added 1.77%	1,008,919 $36.3 Million
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $14.6 Million - $16.3 Million	-393,640 Reduced 28.42%	991,337 $42.9 Million
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $1.34 Million - $1.48 Million	-35,801 Reduced 2.52%	1,384,977 $58.8 Million
Q4 2018 Feb 08, 2019	BUY	$38.47 - $43.86 $8.98 Million - $10.2 Million	233,401 Added 19.66%	1,420,778 $62 Million
Q3 2018 Nov 08, 2018	BUY	$34.47 - $41.81 $1.91 Million - $2.32 Million	55,494 Added 4.9%	1,187,377 $52.3 Million
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $4.77 Million - $5.08 Million	144,505 Added 14.64%	1,131,883 $41.1 Million
Q1 2018 May 10, 2018	BUY	$31.91 - $37.02 $3.55 Million - $4.12 Million	111,237 Added 12.7%	987,378 $35 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $3.12 Million - $3.31 Million	93,767 Added 11.98%	876,141 $31.7 Million
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $24.3 Million - $26.7 Million	782,374	782,374 $27.9 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

News

Stay updated on Norinchukin Bank, The with notifications on news.

Account

Norinchukin Bank, The Pfizer Inc Transaction History